© 2021 MJH Life Sciences and Drug Topics. All rights reserved.
© 2021 MJH Life Sciences™ and Drug Topics. All rights reserved.
May 17, 2021
From the chairman
More than a year into the COVID-19 pandemic, the mental health burden resulting from the public health crisis is becoming more and more apparent.
May 13, 2021
Innovation is everywhere, but cumbersome pharmacy technology remains an issue.
May 12, 2021
Pharmacist inclusion in stroke interventions improves patient outcomes.
May 11, 2021
Melphalan flufenamide (Pepaxto; Oncopeptides AB) in combination with dexamethasone was granted accelerated approval on February 26, 2021, by the FDA for adult patients with relapsed or refractory multiple myeloma.
May 10, 2021
Ease patients’ concerns by being well versed in the safety profiles of each vaccine.
May 06, 2021
Pharmacists can play an important role as part of an interdisciplinary team in treating patients with rheumatoid arthritis.
May 05, 2021
Technology and mobile health apps can be valuable tools in diabetes management.
May 04, 2021
More opportunities are emerging for pharmacists to fine-tune their patients’ regimens and serve as important access points for individuals experiencing mental health crises.